This ad will auto close in 10 seconds

'Glivec patent denial to hit investment in med advancement'

Indian Supreme Court's decision Monday to deny patent to Swiss firm Novartis for its cancer drug Glivec will negatively impact the ability of companies to invest in medical and technological advancements, the US Chamber of Commerce said.